Natera, Inc.
NTRANasdaqServices-Medical LaboratoriesFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 7, 2026Score 10/30206% above fair value
$378.92−35.38 (-8.54%)
Close on Nov 2, 2026Market cap $54.62BP/E –Yield –
Natera Operating Cash Outflows for Operating Leases by Year
Operating Cash Outflows for Operating Leases ($M) ($M)
Natera Operating Cash Outflows for Operating Leases: $19.8M in FY2025, up 17.9% from a year earlier. That is the highest of the 8 years on record here.
Latest, FY2025
19.8
Period ended Dec 31, 2025
Change on a year earlier
+17.9%
16.8 in FY2024
History
8 years
Since FY2018
Sources
6
Documents cited below
Where the FY2025 figure comes from
Source: Form 10-K (2026-02-27) ↗
Reported in Form 10-K/10-Q Note — Leases (XBRL).
Annual history
Hover a value to see the sentence it was read from; calculated values show their formula
| Period | Ended | Operating Cash Outflows for Operating Leases ($M) ($M) | Year on year | Source |
|---|---|---|---|---|
| FY2025 | Dec 31, 2025 | 19.8 | +17.9% | Form 10-K (2026-02-27) ↗ |
| FY2024 | Dec 31, 2024 | 16.8 | +35.5% | Form 10-K (2026-02-27) ↗ |
| FY2023 | Dec 31, 2023 | 12.4 | +31.9% | Form 10-K (2026-02-27) ↗ |
| FY2022 | Dec 31, 2022 | 9.40 | -8.7% | Form 10-K (2025-02-28) ↗ |
| FY2021 | Dec 31, 2021 | 10.3 | +14.4% | Form 10-K (2024-02-29) ↗ |
| FY2020 | Dec 31, 2020 | 9 | +4.7% | Form 10-K (2023-03-01) ↗ |
| FY2019 | Dec 31, 2019 | 8.60 | +8.9% | Form 10-K (2022-02-25) ↗ |
| FY2018 | Dec 31, 2018 | 7.90 | – | Form 10-K (2021-02-26) ↗ |
Cite this data
StockData. (2026). Natera Operating Cash Outflows for Operating Leases ($M), annual FY2018–FY2025 [Data set]. Compiled from Natera SEC filings and investor materials. https://stockdatahq.com/stocks/ntra/kpis/lease-cash-payments
See every metric in the Natera KPI table. Data updated Nov 2, 2026.